• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Latest Bionic Eye Developments Indicate Bright Future for Ocular Medical Devices

by HITC Staff 01/17/2016 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

The recent announcement by the Clinical Ophthalmology Research Group at the University of Oxford that two patients were able to achieve some restoration of vision following implantation of the Alpha IMS device puts maker Retina Implant AG ahead of the pack in the bionic eye space, according to an analyst with research and consulting firm GlobalData. 

Shashank Settipalli, GlobalData’s Analyst covering Medical Devices, says: “These promising results, in conjunction with a string of positive developments for Retina Implant AG that included the CE mark and reimbursement approval in Germany for the first-generation Alpha IMS device, continue to bolster the company’s standing in the burgeoning retinal prosthesis market.”

The Alpha IMS implant features an array of photosensitive electrodes, which replace the function of damaged or dead cellular photoreceptors. The device is implanted directly in the retina and is powered by a small, subcutaneous battery placed behind the ear.

The analyst continues: “Retina Implant AG’s technology has distinct advantages over Second Sight, its biggest competitor in the retinitis pigmentosa space, and maker of the Argus II system, which was approved nearly half a decade ago to offer some relief from ocular problems caused by the condition.

“Unlike the Argus II, the Alpha IMS device does not require an external camera or video processing unit. By leveraging these advantages and positive clinical results, Retina Implant AG has ample opportunities to expand its presence in the ocular devices space.”

Despite recent progress, visual impairment remains one of most debilitating indications under-addressed by the medical devices market. However, as more ocular devices gain regulatory and reimbursement approval in global markets, medical device firms have much to gain in a dynamic medical technology arena, according to GlobalData.

Settipalli concludes: “Start-up and mid-size ophthalmic device companies could appeal to investors encouraged by recent developments, whereas the larger multinational firms may seek new growth strategies through acquisitions and strong research and development efforts.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Bionic Eye, Ocular Medical Devices

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Knowledge Hub

 How Top Health Plans Use AI to Save Money and Work Smarter How Top Health Plans Use AI to Save Money and Work Smarter

 How to Build Hybrid Care Models Around Remote Patient Monitoring How to Build Hybrid Care Models Around Remote Patient Monitoring

Trending

Metriport Launches Open-Source API to Instantly Pull Medical Records from Any EHR

Metriport Launches Open-Source API to Instantly Pull Medical Records from Any EHR

Nearly Half Of Consumers Report Their Healing has Been Directly Impacted by Difficulty Paying Medical Bills

Consumers Cite Healthcare Affordability as Biggest Concern to Paying Medical Bills

Mayo Clinic, GE HealthCare, Partner on Medical Imaging and Theranostics Innovation

Roundups: 16 Recent Strategic Digital Health Partnerships

How Telehealth Can Combat Clinician Burnout

How Telehealth Can Combat Clinician Burnout

Q/A: DocStation CEO Shares How AI Will Help Pharmacies Use the DIR Fee Changes to Their Advantage

Q/A: DocStation CEO Shares How AI Will Help Pharmacies Use the DIR Fee Changes to Their Advantage

Debunking Myths About Virtual Care to Drive Health Equity

Debunking 3 Myths About Virtual Care to Drive Health Equity

Provider AI Strategy Moves From The IT Dept. To The C-Suite

Notable Launches ChatGPT-Like Assistant for Patients

Notable Launches ChatGPT-Like Assistant for Patients

Intermountain to Replace Cerner with Epic Enterprise EHR by 2025

Intermountain to Replace Cerner with Epic Enterprise EHR by 2025

M&A: PE Firm Acquires NextGen Healthcare EHR for $1.8B

M&A: NextGen Healthcare EHR Acquired by PE Firm for $1.8B

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |